EADV Congress

1 poster presented

Schlesinger, T., Patel, V.A., Rigel, D., Kircik, L., Berman, B., Lebwohl, M., Armstrong, A., Del Rosso, J., Bhatia, N., Narayanan, S., Koscielny, V., & Kasujee, I. (2023). Impact of tirbanibulin 1% treatment on symptoms, emotions, and functioning in different subgroups of patients with Actinic Keratosis in routine clinical practices across the U.S. (PROAK Study). Accepted for presentation at 32nd EADV Congress; October 11th-14th, 2023. Berlin, Germany.

 

To request more information, send us an email at info@avant-health.com

Copyright © 2020 Avant Health. All rights reserved.